ArticleThoracic cancer2022

Disease monitoring of epidermal growth factor receptor (EGFR)-mutated non-small-cell lung cancer patients treated with tyrosine kinase inhibitors via EGFR status in circulating tumor DNA.

Yan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.